FMP

FMP

Enter

MJNA - Medical Marijuana, I...

photo-url-https://images.financialmodelingprep.com/symbol/MJNA.png

Medical Marijuana, Inc.

MJNA

PNK

Medical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. It focuses on the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol (CBD) and other products containing CBD-rich hemp oil; treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products; and nonpsychoactive cannabidiol products. The company is also involved in the research and development of new therapeutic agents that are designed to reduce oxidative stress and act as immuno-modulators and neuroprotectants; dietary supplements, skin care products, and prescription-based hemp oil under the Kannaway and HempMeds brands; and proprietary testing, genetics, labeling and packaging, tracking, and production and standardization methods for the medicinal cannabinoid industry. In addition, it offers RSHO oil for the treatment of various illnesses and conditions; and plant-based, non-GMO pet products for health and wellness, play and wear, and environmentally-friendly supplies. Medical Marijuana, Inc. was incorporated in 2005 and is based in San Diego, California.

0.0003 USD

0.0001 (33.33%)

Free Cash Flow

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Revenue

46.94M

34.12M

25.1M

16.81M

14.91M

11.25M

8.49M

6.41M

4.84M

3.65M

Revenue %

-

-27.3

-26.45

-33.02

-11.33

-24.52

-24.52

-24.52

-24.52

Operating Cash Flow

-95.95M

-4.48M

-14.75M

-2.54M

977.3k

-4.06M

-3.06M

-2.31M

-1.75M

-1.32M

Operating Cash Flow %

-204.42

-13.12

-58.78

-15.12

6.56

-36.09

-36.09

-36.09

-36.09

Cap Ex

-

-23.99k

-2.86M

-4.36M

-

-841.59k

-635.2k

-479.43k

-361.85k

-273.11k

Cap Ex %

-

-0.07

-11.39

-25.94

-

-7.48

-7.48

-7.48

-7.48

Free Cash Flow

-95.95M

-4.5M

-17.61M

-6.9M

977.3k

-4.9M

-3.7M

-2.79M

-2.11M

-1.59M

Weighted Average Cost Of Capital

Price

0

Beta

Diluted Shares Outstanding

6.77B

Costof Debt

10.31

Tax Rate

After Tax Cost Of Debt

10.31

Risk Free Rate

Market Risk Premium

Cost Of Equity

Total Debt

2.85M

Total Equity

2.03M

Total Capital

4.88M

Debt Weighting

58.35

Equity Weighting

41.65

Wacc

10.42

Build Up Free Cash Flow

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Revenue

46.94M

34.12M

25.1M

16.81M

14.91M

11.25M

8.49M

6.41M

4.84M

3.65M

Operating Cash Flow

-95.95M

-4.48M

-14.75M

-2.54M

977.3k

-4.06M

-3.06M

-2.31M

-1.75M

-1.32M

Cap Ex

-

-23.99k

-2.86M

-4.36M

-

-841.59k

-635.2k

-479.43k

-361.85k

-273.11k

Free Cash Flow

-95.95M

-4.5M

-17.61M

-6.9M

977.3k

-4.9M

-3.7M

-2.79M

-2.11M

-1.59M

Wacc

10.42

10.42

10.42

10.42

10.42

Pv Lfcf

-4.44M

-3.03M

-2.07M

-1.42M

-969.02k

Sum Pv Lfcf

-11.93M

Terminal Value

Growth In Perpetuity Method

Long Term Growth Rate

Wacc

10.42

Free Cash Flow T1

-1.62M

Terminal Value

-19.26M

Present Terminal Value

-11.73M

Intrinsic Value

Enterprise Value

-23.67M

Net Debt

1.81M

Equity Value

-25.48M

Diluted Shares Outstanding

6.77B

Equity Value Per Share

-0

Projected DCF

-0.00376193 1.08%

DCF Levered

Download Excel

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2025 © Financial Modeling Prep